Approvals/TGA/AIMOVIG erenumab (rch) 70 mg/mL solution for injection in pre-filled syringe

Approved

STANDARD

AIMOVIG erenumab (rch) 70 mg/mL solution for injection in pre-filled syringe

Approval Id: cfa840baae139b6a
Product Name: AIMOVIG erenumab (rch) 70 mg/mL solution for injection in pre-filled syringe
Artg Id: 289960
Artg Name: AIMOVIG erenumab (rch) 70 mg/mL solution for injection in pre-filled syringe
Sponsor: Novartis Pharmaceuticals Australia Pty Ltd
Company Detail Path: /organization/novartis-pharmaceuticals-australia-pty-ltd
Artg Date: 2018-07-02
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Product Information: http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2018-PI-02021-1

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

cfa840baae139b6a

Type

Standard